News

The Wojcicki sisters were raised in a quiet Silicon Valley suburb by their mother, Esther Wojcicki, a renowned educator and ...
Turns out the real stars at Cannes this year weren’t AI bots or brand mascots, they were creators, armed with ring lights.
Google-owned YouTube will lean into the artificial intelligence craze by integrating its own generative AI tool Veo 3 into ...
23andMe co-founder and former CEO Anne Wojcicki is set to buy back the company after it filed for Chapter 11 bankruptcy protection earlier this year. On Friday, 23andMe and TTAM Research Institute ...
Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.
Anne Wojcicki and her nonprofit TTAM Research Institute, discussed their plans for 23andMe in bankruptcy court filings ahead of a hearing that could determine if they take over the company that ...
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO, Anne Wojcicki.
Anne Wojcicki’s nonprofit wins bid for genetic testing company 23andMe Anne Wojcicki, the former chief executive of 23andMe, speaks at UC San Francisco’s Genentech Hall in 2013.
Wojcicki was 23andMe's CEO until it filed for Chapter 11 bankruptcy protection in March, and she continued to hold a controlling stake in the company, which once was valued at $6 billion.
Anne Wojcicki is poised to regain control of 23andMe MEHCQ 6.60%, after a nonprofit she controls topped Regeneron’s bid for the DNA-testing company, according to people familiar with the matter.